Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Recurrence × Radiation × Clear all

Phase

Status

Terminated 2 Withdrawn 1 Unknown 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 15 Esophageal Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 6 Rectal Neoplasms 6 Oropharyngeal Neoplasms 6 Glioma 6 Breast Neoplasms 6 Mouth Neoplasms 5 Glioblastoma 5 Pancreatic Neoplasms 4 Lung Neoplasms 4 Head and Neck Neoplasms 4 Urinary Bladder Neoplasms 3 Sarcoma 3 Multiple Myeloma 3 Laryngeal Neoplasms 3 Brain Neoplasms 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Nasopharyngeal Carcinoma 2 Melanoma 2 Medulloblastoma 2 Hypopharyngeal Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Wilms Tumor 1

Interventions

venetoclax 19 Cyclophosphamide 17 pembrolizumab 15 Dexamethasone 14 Cytarabine 12 fludarabine 11 Azacitidine 10 Gemcitabine 9 pomalidomide 7 Rituximab 7 Carboplatin 7 selinexor 6 glofitamab 6 Temozolomide 6 Lenalidomide 6 Granulocyte Colony-Stimulating Factor 6 fludarabine phosphate 5 Paclitaxel 5 Oxaliplatin 5 Injections 5 Cisplatin 5 zanubrutinib 4 ruxolitinib 4 obinutuzumab 4 daratumumab 4 carfilzomib 4 Surgical Procedures, Operative 4 Nivolumab 4 Decitabine 4 Cladribine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03970447 2025-09-09

GBM AGILE

Global Coalition for Adaptive Research

Phase 2/3 Recruiting

Glioblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡